1. Home
  2. OGEN vs BTBD Comparison

OGEN vs BTBD Comparison

Compare OGEN & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.58

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Logo BT Brands Inc.

BTBD

BT Brands Inc.

HOLD

Current Price

$1.11

Market Cap

10.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGEN
BTBD
Founded
1996
1987
Country
United States
United States
Employees
N/A
188
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
10.0M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
OGEN
BTBD
Price
$0.58
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.5K
267.9K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$1.03
52 Week High
$9.16
$5.59

Technical Indicators

Market Signals
Indicator
OGEN
BTBD
Relative Strength Index (RSI) 43.53 33.86
Support Level N/A N/A
Resistance Level $0.66 $1.62
Average True Range (ATR) 0.04 0.14
MACD -0.00 -0.10
Stochastic Oscillator 32.34 6.25

Price Performance

Historical Comparison
OGEN
BTBD

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

Share on Social Networks: